site stats

Certara press release

WebApr 10, 2024 · PRINCETON, N.J., April 10, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release … WebApr 5, 2024 · d3 Medicine and the Defence Science and Technology (DST) Group will review the country’s medical countermeasures product R&D skills and infrastructure . PRINCETON, NJ – Apr. 5. 2024 – Certara ®, the leading provider of decision support technology and consulting services for optimizing drug development and improving …

Arsenal Capital Partners Acquires Leading Model-based Drug ... - Certara

WebAug 11, 2014 · Certara’s solutions, which span the discovery, preclinical and clinical stages of drug development, enable data-driven decisions, leading to more precisely designed trials with a reduced risk of failure and improved subject safety. Certara Contact: Teresa A. Bradford, 919-852-4644 Senior Director, Marketing [email protected]. … WebSep 30, 2024 · Certara’s Regulatory Science team has leveraged Synchrogenix Writer to deliver more than 10,000 patient narratives, through technology-driven services for the life science industry. The team provided expert insight during the product development process to ensure that the software meets high quality standards and evolving global regulatory ... bolt of gransax mod https://jessicabonzek.com

Certara to Report First Quarter 2024 Financial Results on …

WebApr 10, 2024 · /EIN News/ -- PRINCETON, N.J., April 10, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2024 after the market close on Monday, May 8 th, 2024. Company management will host a conference call to discuss financial results … WebDec 3, 2024 · PRINCETON, NJ.—. December 3, 2024 – Certara, Inc. (“Certara”) today announced the launch of its initial public offering of 24,390,000 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 14,630,000 shares of common stock and certain selling ... WebMar 7, 2024 · Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel drugs in lieu of conducting clinical studies. PRINCETON, N.J.— March 7, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Simulator Version 22, which includes new capabilities and updated … bolt of gransax moveset

Certara to Report First Quarter 2024 Financial Results on

Category:Certara Announces Release of Pinnacle 21 Enterprise Software

Tags:Certara press release

Certara press release

News Release Detail - ir.certara.com

WebSep 1, 2024 · September 1, 2024. PRINCETON, N.J.—September 1, 2024 . Certara, the global leader in biosimulation, today announced changes to its board of directors, which took effect August 26, 2024. After successfully transitioning the leadership of Certara to Chief Executive Officer William Feehery, Edmundo Muniz has decided to step down from the … WebAug 5, 2024 · Total revenue for the second quarter of 2024 was $70.1 million, representing year-over-year growth of 15%. The revenue growth was driven by both technology-driven services and software licenses and subscriptions. Total cost of revenue for the second quarter of 2024 was $27.5 million, an increase from $20.6 million in the second quarter of …

Certara press release

Did you know?

WebMar 2, 2024 · PRINCETON, NJ.—. March 2, 2024– Certara, Inc., a global leader in biosimulation, today announced the acquisition of AUTHOR!, a company that provides medical writing and statistical analysis of clinical trial data to global pharmaceutical and biotechnology companies. Founded in 1998, AUTHOR! is based near Amsterdam in the … WebFeb 3, 2016 · Certara biosimulation (model based drug development and informatics) software portfolio is the most wide-ranging in the industry. Certara technology is relied …

WebMar 9, 2024 · February 27, 2024 16:30 ET Source: Certara. PRINCETON, N.J., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company ... WebSep 13, 2024 · About Certara. Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,650+ global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries. Contacts. …

WebMay 16, 2024 · May 16, 2024. PRINCETON, NJ – May 16, 2024 – Certara® the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced today that it has appointed Dr. William F. Feehery as its new Chief Executive Officer (CEO) and a member of the Certara Board of Directors, … WebMar 1, 2024 · News Releases. Certara to Report First Quarter 2024 Financial Results on May 8th, 2024 and Participate in the BofA Securities 2024 Healthcare Conference. Apr …

WebCertara summarizes how services and software have supported 90% of new drugs approved by the FDA since 2014. ... Latest News. Certara to Report First Quarter 2024 Financial Results on May 8th, 2024 and Participate in the BofA Securities 2024 Healthcare Conference ... Press Release. Drug Discovery & Development with Deep Learning …

WebMar 9, 2024 · February 27, 2024 16:30 ET Source: Certara. PRINCETON, N.J., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in … bolt of gransax fextralifeWebSep 3, 2024 · September 3, 2024. PRINCETON, N.J.—September 3, 2024. Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering … bolt of gransax city of ashWebDec 13, 2024 · PRINCETON, N.J., Dec. 13, 2024 — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the feature release of Pinnacle 21 Enterprise 5.1.0, which updates the Company’s flagship software for preparing clinical trial data for biosimulation and regulatory submission. “With today’s announcement, we are just ... gmb harrogateWebApr 10, 2024 · PRINCETON, N.J., April 10, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release … gmbh and co kgWebApr 10, 2024 · PRINCETON, N.J., April 10, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release … bolt of gransax loreWebMar 1, 2024 · Total cost of revenue for the fourth quarter of 2024 was $29.3 million, a decrease from $34.9 million in the fourth quarter of 2024, primarily due to a $7.2 million … gmb hashtag twitterWebMar 1, 2024 · PRINCETON, N.J. , Feb. 01, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release … bolt of gransax any good